Question 90
A European privacy professional is asked to assess a documented client matter. The supplied case facts are: A medical platform replaces patient names with tokens but retains a protected reidentification key; its marketing memo calls the resulting records anonymous. Which legal reasoning best supports that response for the stated facts?
Explanation
Correct Answer
This explains the applicable privacy-law treatment in the initial client-advisory file. The practical consequence is to classify the tokenised data as pseudonymous rather than anonymous while identification remains possible using additional information. The finding specifically concerns: A medical platform replaces patient names with tokens but retains a protected reidentification key; its marketing memo calls the resulting records anonymous.
Incorrect Answers
The suggested legal explanation concerns a different privacy-law situation: An exposed set of sensitive account credentials is likely to create high risk for affected people, yet the controller assumes authority notification alone always suffices. In the initial client-advisory file, the case file instead describes: A medical platform replaces patient names with tokens but retains a protected reidentification key; its marketing memo calls the resulting records anonymous. For this specific issue, the governing distinction is: Pseudonymisation reduces linkability but does not remove GDPR scope when reidentification remains reasonably possible. Therefore this alternative would not directly meet the stated assessment need.
The suggested legal explanation concerns a different privacy-law situation: An access request reaches the controller, but staff insist that all GDPR rights requests always take three months before any reply. In the initial client-advisory file, the case file instead describes: A medical platform replaces patient names with tokens but retains a protected reidentification key; its marketing memo calls the resulting records anonymous. For this specific issue, the governing distinction is: Pseudonymisation reduces linkability but does not remove GDPR scope when reidentification remains reasonably possible. Therefore this alternative would not directly meet the stated assessment need.
The suggested legal explanation concerns a different privacy-law situation: A consumer withdraws a previously valid opt-in for optional personalised offers but the controller tells them withdrawal has no effect. In the initial client-advisory file, the case file instead describes: A medical platform replaces patient names with tokens but retains a protected reidentification key; its marketing memo calls the resulting records anonymous. For this specific issue, the governing distinction is: Pseudonymisation reduces linkability but does not remove GDPR scope when reidentification remains reasonably possible. Therefore this alternative would not directly meet the stated assessment need.





Certified Information Privacy Professional/Europe (CIPP/E) (CIPP-E) Practice Tests